Matt666, looking at the trials status from the coy's cowen conference slides we have 2 HA trials that are pre phase 2 being HA-Doxorubicin and HA-5FU. These would obviously be continued into phase 2 if they were to beef up their trials progress.
The question is how much cash is required to take these 2 through phase 2 as this would be part of the equation when calculating cash requirements at the onco IPO.
Any ideas out there?
its all looking positive, page-24
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable